company background image
002880 logo

Shenzhen Weiguang Biological Products SZSE:002880 Stock Report

Last Price


Market Cap







18 Jul, 2024


Company Financials +

Shenzhen Weiguang Biological Products Co., Ltd.

SZSE:002880 Stock Report

Market Cap: CN¥6.3b

Shenzhen Weiguang Biological Products Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shenzhen Weiguang Biological Products
Historical stock prices
Current Share PriceCN¥27.90
52 Week HighCN¥38.93
52 Week LowCN¥22.05
11 Month Change-2.07%
3 Month Change0%
1 Year Change-26.58%
33 Year Change-27.44%
5 Year Change24.69%
Change since IPO62.03%

Recent News & Updates

Recent updates

Shareholder Returns

002880CN BiotechsCN Market

Return vs Industry: 002880 underperformed the CN Biotechs industry which returned -20.5% over the past year.

Return vs Market: 002880 underperformed the CN Market which returned -18.2% over the past year.

Price Volatility

Is 002880's price volatile compared to industry and market?
002880 volatility
002880 Average Weekly Movement4.8%
Biotechs Industry Average Movement6.1%
Market Average Movement5.9%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market4.0%

Stable Share Price: 002880 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002880's weekly volatility (5%) has been stable over the past year.

About the Company


Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous human immunoglobulin (pH4), rabies immunoglobulin, human fibrinogen, coagulation factor, trace proteins, as well as a total of 9 varieties and 21 specifications.

Shenzhen Weiguang Biological Products Co., Ltd. Fundamentals Summary

How do Shenzhen Weiguang Biological Products's earnings and revenue compare to its market cap?
002880 fundamental statistics
Market capCN¥6.33b
Earnings (TTM)CN¥219.75m
Revenue (TTM)CN¥1.07b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002880 income statement (TTM)
Cost of RevenueCN¥622.14m
Gross ProfitCN¥444.14m
Other ExpensesCN¥224.40m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 28, 2024

Earnings per share (EPS)0.97
Gross Margin41.65%
Net Profit Margin20.61%
Debt/Equity Ratio31.3%

How did 002880 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.